Cover Image
市場調查報告書

胎兒監測的全球市場:市場分析,企業簡介,市場規模,市場佔有率,成長,趨勢,市場預測

Global Fetal Monitoring Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

出版商 Data Bridge Market Research Private Limited 商品編碼 587844
出版日期 內容資訊 英文 350 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
胎兒監測的全球市場:市場分析,企業簡介,市場規模,市場佔有率,成長,趨勢,市場預測 Global Fetal Monitoring Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
出版日期: 2017年10月01日 內容資訊: 英文 350 Pages
簡介

本報告提供胎兒監測的全球市場調查,市場概要,各產品、可攜帶性、侵入性、用途、終端用戶、流通管道、地區的市場趨勢,市場規模的變化與預測,市場的推動要素以及市場機會、課題分析,市場佔有率,競爭情形,主要企業簡介等,總括性彙整。

第1章 簡介

第2章 市場區隔

  • 重要點
  • 市場規模
    • 企業的收益額、市場佔有率分析
    • 三角測量法
    • 從1次資訊來源取得的資料、論點
    • 從2次資訊來源取得的資料、論點
    • 波特的五力分析
    • PEST分析
    • 患者數預測模式
  • 調查概要
  • 前提條件

第3章 市場概要

  • 市場的推動要素
  • 市場阻礙因素
  • 市場機會
  • 課題

第4章 摘要整理

第5章 重要考察

第6章 胎兒監測的全球市場:各產品

  • 市場概要
  • 監測設備、消耗品
    • 超音波螢幕
    • 母體/胎兒電子螢幕
    • 孩子頭電極
    • 多普勒胎兒心率儀
    • 分娩監測儀
    • 遙測
    • 配件、消耗品
    • 其他
  • 軟體

第7章 胎兒監測的全球市場:各可攜帶性

  • 市場概要
  • 一體型系統
  • 可攜式系統
  • 穿戴式系統

第8章 胎兒監測的全球市場:各侵入性

  • 市場概要
  • 非侵入性監測
  • 侵入性監測

第9章 胎兒監測的全球市場:各用途

  • 市場概要
  • 分娩前胎兒監測
  • 分娩時胎兒監測

第10章 胎兒監測的全球市場:各終端用戶

  • 市場概要
  • 醫院
  • 產科、婦產科
  • 居家照護

第11章 胎兒監測的全球市場:各流通管道

  • 市場概要
  • 直接競標
  • 零售

第12章 胎兒監測的全球市場:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲
  • 主要國家分析

第13章 競爭環境

  • 企業的市場佔有率:各地區
  • 合併、收購
  • 新產品的開發、核准
  • 事業擴大
  • 法規環境的變化
  • 夥伴關係、其他策略趨勢

第14章 企業簡介

  • ANALOGIC CORPORATION
  • FUJIFILM SONOSITE, INC.
  • GE HEALTHCARE
  • PHILIPS HEALTHCARE
  • SIEMENS HEALTHCARE
  • COVIDIEN PLC
  • ARJOHUNTLEIGH
  • NEOVENTA MEDICAL AB
  • BRIGGS HEALTHCARE
  • NATUS MEDICAL INCORPORATED
  • SPACELABS HEALTHCARE
  • EDAN INSTRUMENTS, INC.
  • COOPERSURGICAL INC.
  • NEOVENTA MEDICAL AB
  • MEDTRONIC PLC

第15章 附錄

第16章 關於Data Bridge Market Research

目錄

Title:
Global Fetal Monitoring Market
By Product Type (Instruments & Consumables {Ultrasound (2D Ultrasound, 3D & 4D Ultrasound), Electronic Maternal/Fetal Monitor (External Monitor, Internal Monitors), Fetal Electrodes, Fetal Doppler, Telemetry Solutions, Accessories & Consumables}, Software), By Portability {Standalone Systems, Portable Systems (Wearable Systems, Non-Wearable Systems)}, By Methods (Non-Invasive, Invasive), By Application (Antepartum, Intrapartum), By End User (Hospitals, Gynecological/Obstetrics Clinics, Homecare, Others), By Distribution Channel (Direct Tender, Retail), By Region (North America, Europe, Asia-Pacific, South America and Middle East & Africa) - Industry Trends and Forecast to 2024.

Global Fetal Monitoring Market is expected to reach USD 3,245.49 million by 2024 from USD 1,954.00 million in 2016, at a CAGR of 6.7% in the forecast period 2017 to 2024.

The major factors driving the growth of this market are the increasing birth rates and preterm births, technological advancements and new product launch, government and non-government funds for the best facilities.

The key market players for Global Fetal Monitoring Market are listed below:

  • Koninklijke Philips N.V.,
  • Fujifilm Holding Corporation and Siemens
  • Edan Instruments Inc.,
  • Neoventa Medical AB,
  • Medtronic,
  • Natus Medical incorporated,
  • Cooper Companies, Inc.,
  • MedGyn Products Inc.,
  • Dixion, Lutech Industries Inc,
  • Advanced Instruments, Inc,
  • Shenzhen Bestman Instrument Co., Ltd.,
  • TRISMED Co., LTD,
  • Progetti Srl,
  • ArjoHuntleigh,
  • Analogic Corporation,
  • Wallach Surgical Devices,
  • OSI System Inc.

The market is further segmented into:

  • Type
  • Material
  • End User
  • Geography

The global fetal monitoring market is segmented on the basis of product type, portability, methods, application, end users and distribution channel. Based on product type, the global fetal monitoring market is segmented into instruments & consumables and software.

On the basis of portability, the global fetal monitoring market is segmented into standalone systems and portable systems. Portable systems are further sub segmented into wearable systems and non-wearable systems. In 2017, the standalone segment is expected to dominate the market with 70.3% market share.

On the basis of methods, the global fetal monitoring market is segmented into non-invasive method and invasive method.

By application, the global fetal monitoring market is segmented into antepartum fetal monitoring and intrapartum fetal monitoring. Antepartum is the most common and the highest growing segment with the highest CAGR of 7.6% in the forecast period 2017 to 2024.

On the basis of end users, the global fetal monitoring market is classified into hospitals, gynecological/obstetrics clinics, homecare and others. Among these, in 2017 hospitals segment dominated the market and the trend is expected to remain the same till 2024.

On the basis of distribution channel, the global fetal monitoring market is classified into direct tender and retail. Among these, in 2017 direct tender segment dominated the market and the trend is expected to remain the same till 2024.

Based on geography, the Global Fetal Monitoring market is segmented into geographical regions, such as,

  • North America,
  • Europe,
  • Asia-Pacific,
  • South America
  • Middle East & Africa

Covered in this report:

The report covers the present scenario and the growth prospects of the Global Fetal Monitoring market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

1. INTRODUCTION

  • 1.1. OVERVIEW OF THE GLOBAL FETAL MONITORING MARKET
  • 1.2. CURRENCY AND PRICING
  • 1.3. LIMITATION
  • 1.4. MARKETS COVERED

2. MARKET SEGMENTATION

  • 2.1. KEY TAKEAWAYS
  • 2.2. ARRIVING AT THE GLOBAL FETAL MONITORING MARKET SIZE
    • 2.2.1. MARKET CRACKDOWN APPROACH
    • 2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
    • 2.2.3. DATA TRIANGULATION
    • 2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
    • 2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
    • 2.2.6. PORTER'S FIVE FORCES MATRIX
    • 2.2.7. PEST ANALYSIS
    • 2.2.8. EPIDEMIOLOGY FORECASTING MODELS
  • 2.3. GLOBAL FETAL MONITORING MARKET: RESEARCH SNAPSHOT
  • 2.4. ASSUMPTIONS

3. MARKET OVERVIEW

  • 3.1. DRIVERS
  • 3.2. RESTRAINTS
  • 3.3. OPPORTUNITIES
  • 3.4. CHALLENGES

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. GLOBAL FETAL MONITORING MARKET, BY PRODUCT

  • 6.1. OVERVIEW
  • 6.2. INSTRUMENTS & CONSUMABLES
    • 6.2.1. ULTRASOUND
      • 6.2.1.1. 2D ULTRASOUND
      • 6.2.1.2. 3D & 4D ULTRASOUND
      • 6.2.1.3. DOPPLER IMAGING
    • 6.2.2. ELECTRONIC MATERNAL/FETAL MONITOR
      • 6.2.2.1. EXTERNAL MONITOR
      • 6.2.2.2. OTHER MONITORS
    • 6.2.3. FETAL ELECTRODES
      • 6.2.3.1. DIGITAL BLOOD PRESSURE MONITORS
      • 6.2.3.2. ANEROID BLOOD PRESSURE MONITORS
      • 6.2.3.3. WEARABLE BLOOD PRESSURE MONITORS
    • 6.2.4. FETAL DOPPLER
    • 6.2.5. UTERINE CONTRACTION MONITOR
      • 6.2.3.1. EXTERNAL MONITORING
      • 6.2.3.2. INTERNAL MONITORING
    • 6.2.6. TELEMETRY SOLUTIONS
    • 6.2.7. ACCESSORIES & CONSUMABLES
    • 6.2.8. OTHER PRODUCTS
  • 6.3. SOFTWARE

7. GLOBAL FETAL MONITORING MARKET, BY PORTABILITY

  • 7.1. OVERVIEW
  • 7.2. STANDALONE SYSTEMS
  • 7.3. PORTABLE SYSTEMS
  • 7.4. WEARABLE SYSTEMS

8. GLOBAL FETAL MONITORING MARKET, BY METHOD

  • 8.1. OVERVIEW
  • 8.2. NON-INVASIVE
  • 8.3. INVASIVE

9. GLOBAL FETAL MONITORING MARKET, BY APPLICATION

  • 9.1. OVERVIEW
  • 9.2. ANTEPARTUM FETAL MONITORING
  • 9.3. INTRAPARTUM FETAL MONITORING

10. GLOBAL FETAL MONITORING MARKET, BY END USER

  • 10.1. OVERVIEW
  • 10.2. HOSPITALS
  • 10.3. GYNECOLOGICAL/OBSTETRICS CLINICS
  • 10.4. HOMECARE
  • 10.5. OTHERS

11. GLOBAL FETAL MONITORING MARKET, BY DISTRIBUTION CHANNEL

  • 11.1. OVERVIEW
  • 11.2. DIRECT TENDER
  • 11.3. RETAIL 

12. GLOBAL FETAL MONITORING MARKET, BY COUNTRY

  • 12.1. COUNTRYWISE GLOBAL FETAL MONITORING MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
    • 12.1.1. NORTH AMERICA
      • 12.1.1.1. U.S.
      • 12.1.1.2. CANADA
      • 12.1.1.3. MEXICO
    • 12.1.2. EUROPE
      • 12.1.2.1. GERMANY
      • 12.1.2.2. FRANCE
      • 12.1.2.3. U.K.
      • 12.1.2.4. ITALY
      • 12.1.2.5. SPAIN
      • 12.1.2.6. RUSSIA
      • 12.1.2.7. TURKEY
      • 12.1.2.8. BELGIUM
      • 12.1.2.9. NETHERLANDS
      • 12.1.2.10. SWITZERLAND
      • 12.1.2.11. REST OF EUROPE
    • 12.1.3. ASIA-PACIFIC (APAC)
      • 12.1.3.1. JAPAN
      • 12.1.3.2. CHINA
      • 12.1.3.3. SOUTH KOREA
      • 12.1.3.4. INDIA
      • 12.1.3.5. AUSTRALIA
      • 12.1.3.6. SINGAPORE
      • 12.1.3.7. THAILAND
      • 12.1.3.8. MALAYSIA
      • 12.1.3.9. INDONESIA
      • 12.1.3.10. PHILIPPINES
      • 12.1.3.11. REST OF APAC
    • 12.1.4. LATIN AMERICA
      • 12.1.4.1. BRAZIL
      • 12.1.4.2. REST OF LATIN AMERICA
    • 12.1.5. MIDDLE EAST AND AFRICA
      • 12.1.5.1. SOUTH AFRICA
      • 12.1.5.2. REST OF MIDDLE EAST AND AFRICA
  • 12.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

13. GLOBAL FETAL MONITORING MARKET: COMPETITIVE LANDSCAPE

  • 13.1. GLOBAL FETAL MONITORING MARKET: COMPANY SHARE ANALYSIS

13.2. NORTH AMERICA FETAL MONITORING MARKET:

COMPANY SHARE ANALYSIS

  • 13.3. EUROPE FETAL MONITORING MARKET: COMPANY SHARE ANALYSIS
  • 13.4. APAC FETAL MONITORING MARKET: COMPANY SHARE ANALYSIS
  • 13.5. MEA FETAL MONITORING MARKET: COMPANY SHARE ANALYSIS
  • 13.6. SOUTH AMERICA FETAL MONITORING MARKET: COMPANY SHARE ANALYSIS
  • 13.7. MERGERS & ACQUISITIONS
  • 13.8. NEW PRODUCT DEVELOPMENT & APPROVALS
  • 13.9. EXPANSIONS
  • 13.10. REGULATORY CHANGES
  • 13.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

14. GLOBAL FETAL MONITORING MARKET, COMPANY PROFILES

  • 14.1. ANALOGIC CORPORATION
    • 14.1.1. COMPANY OVERVIEW
    • 14.1.2. FINANCIAL ANALYSIS
    • 14.1.3. PRODUCT MATRIX
    • 14.1.4. RECENT DEVELOPMENTS
    • 14.1.5. DATABRIDGE ANALYSIS
  • 14.2. FUJIFILM SONOSITE, INC.
    • 14.2.1. COMPANY OVERVIEW
    • 14.2.2. FINANCIAL ANALYSIS
    • 14.2.3. PRODUCT MATRIX
    • 14.2.4. RECENT DEVELOPMENTS
    • 14.2.5. DATABRIDGE ANALYSIS
  • 14.3. GE HEALTHCARE
    • 14.3.1. COMPANY OVERVIEW
    • 14.3.2. FINANCIAL ANALYSIS
    • 14.3.3. PRODUCT MATRIX
    • 14.3.4. RECENT DEVELOPMENTS
    • 14.3.5. DATABRIDGE ANALYSIS
  • 14.4. PHILIPS HEALTHCARE
    • 14.4.1. COMPANY OVERVIEW
    • 14.4.2. FINANCIAL ANALYSIS
    • 14.4.3. PRODUCT MATRIX
    • 14.4.4. RECENT DEVELOPMENTS
    • 14.4.5. DATABRIDGE ANALYSIS
  • 14.5. SIEMENS HEALTHCARE
    • 14.5.1. COMPANY OVERVIEW
    • 14.5.2. FINANCIAL ANALYSIS
    • 14.5.3. PRODUCT MATRIX
    • 14.5.4. RECENT DEVELOPMENTS
    • 14.5.5. DATABRIDGE ANALYSIS
  • 14.6. COVIDIEN PLC
    • 14.6.1. COMPANY OVERVIEW
    • 14.6.2. FINANCIAL ANALYSIS
    • 14.6.3. PRODUCT MATRIX
    • 14.6.4. RECENT DEVELOPMENTS
    • 14.6.5. DATABRIDGE ANALYSIS
  • 14.7. ARJOHUNTLEIGH
    • 14.7.1. COMPANY OVERVIEW
    • 14.7.2. FINANCIAL ANALYSIS
    • 14.7.3. PRODUCT MATRIX
    • 14.7.4. RECENT DEVELOPMENTS
    • 14.7.5. DATABRIDGE ANALYSIS
  • 14.8. NEOVENTA MEDICAL AB
    • 14.8.1. COMPANY OVERVIEW
    • 14.8.2. FINANCIAL ANALYSIS
    • 14.8.3. PRODUCT MATRIX
    • 14.8.4. RECENT DEVELOPMENTS
    • 14.8.5. DATABRIDGE ANALYSIS
  • 14.9. BRIGGS HEALTHCARE
    • 14.9.1. COMPANY OVERVIEW
    • 14.9.2. FINANCIAL ANALYSIS
    • 14.9.3. PRODUCT MATRIX
    • 14.9.4. RECENT DEVELOPMENTS
    • 14.9.5. DATABRIDGE ANALYSIS

  • 14.10. NATUS MEDICAL INCORPORATED
    • 14.10.1. COMPANY OVERVIEW
    • 14.10.2. FINANCIAL ANALYSIS
    • 14.10.3. PRODUCT MATRIX
    • 14.10.4. RECENT DEVELOPMENTS
    • 14.10.5. DATABRIDGE ANALYSIS
  • 14.11. SPACELABS HEALTHCARE
    • 14.11.1. COMPANY OVERVIEW
    • 14.11.2. FINANCIAL ANALYSIS
    • 14.11.3. PRODUCT MATRIX
    • 14.11.4. RECENT DEVELOPMENTS
    • 14.11.5. DATABRIDGE ANALYSIS
  • 14.12. EDAN INSTRUMENTS, INC.
    • 14.12.1. COMPANY OVERVIEW
    • 14.12.2. FINANCIAL ANALYSIS
    • 14.12.3. PRODUCT MATRIX
    • 14.12.4. RECENT DEVELOPMENTS
    • 14.12.5. DATABRIDGE ANALYSIS
  • 14.13. COOPERSURGICAL INC.
    • 14.13.1. COMPANY OVERVIEW
    • 14.13.2. FINANCIAL ANALYSIS
    • 14.13.3. PRODUCT MATRIX
    • 14.13.4. RECENT DEVELOPMENTS
    • 14.13.5. DATABRIDGE ANALYSIS
  • 14.14. NEOVENTA MEDICAL AB
    • 14.14.1. COMPANY OVERVIEW
    • 14.14.2. FINANCIAL ANALYSIS
    • 14.14.3. PRODUCT MATRIX
    • 14.14.4. RECENT DEVELOPMENTS
    • 14.14.5. DATABRIDGE ANALYSIS
  • 14.15. MEDTRONIC PLC
    • 14.15.1. COMPANY OVERVIEW
    • 14.15.2. FINANCIAL ANALYSIS
    • 14.15.3. PRODUCT MATRIX
    • 14.15.4. RECENT DEVELOPMENTS
    • 14.15.5. DATABRIDGE ANALYSIS

15. APPENDIX

16. ABOUT DATA BRIDGE MARKET RESEARCH

Back to Top